Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Barroilhet

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Research Square|May 7, 2026
The oxidative phosphorylation inhibitor, atovaquone, upregulates PD-L1 via activation of the ATM/ATR DNA damage response pathwaySejal Sharma, Meghana Roy Peddoddi, Anupama Singh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2023
Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcomeDandi Huang, Ross Harrison, Erin Curtis, et al.
Reproduction (Cambridge, England)|April 17, 2023
Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cellsArvinder Kapur, Jose M Ayuso, Shujah Rehman, et al.
Radiology|July 21, 2017
Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound GuidelinesKatherine E Maturen, Alexander D Blaty, Ashish P Wasnik, et al.
American Journal of Obstetrics and Gynecology|June 1, 2025
Addressing the crisis in women's health research: an American Gynecological and Obstetrical Society statementMostafa A Borahay, Marianna Alperin, David Turok, et al.
Radiology|March 22, 2022
Ovarian Cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at USAkshya Gupta, Priyanka Jha, Timothy M Baran, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 12, 2020
Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patientsJessica Vazquez, Melina Chavarria, Gladys E Lopez, et al.
JAMA Network Open|June 9, 2022
Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United StatesPriyanka Jha, Akshya Gupta, Timothy M Baran, et al.
Gynecologic Oncology|October 10, 2021
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancerJoyce Liu, Howard Burris, Judy S Wang, et al.
Cancer Research|May 10, 2018
Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer CellsMolly J Carroll, Kaitlin C Fogg, Harin A Patel, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Research Square|May 7, 2026
The oxidative phosphorylation inhibitor, atovaquone, upregulates PD-L1 via activation of the ATM/ATR DNA damage response pathwaySejal Sharma, Meghana Roy Peddoddi, Anupama Singh, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 22, 2023
Beyond post-operative readmissions: analysis of the impact of unplanned readmissions during primary treatment of advanced-stage epithelial ovarian cancer on long-term oncology outcomeDandi Huang, Ross Harrison, Erin Curtis, et al.
Reproduction (Cambridge, England)|April 17, 2023
Oxidative phosphorylation inhibitors inhibit proliferation of endometriosis cellsArvinder Kapur, Jose M Ayuso, Shujah Rehman, et al.
Radiology|July 21, 2017
Risk Stratification of Adnexal Cysts and Cystic Masses: Clinical Performance of Society of Radiologists in Ultrasound GuidelinesKatherine E Maturen, Alexander D Blaty, Ashish P Wasnik, et al.
American Journal of Obstetrics and Gynecology|June 1, 2025
Addressing the crisis in women's health research: an American Gynecological and Obstetrical Society statementMostafa A Borahay, Marianna Alperin, David Turok, et al.
Radiology|March 22, 2022
Ovarian Cancer Detection in Average-Risk Women: Classic- versus Nonclassic-appearing Adnexal Lesions at USAkshya Gupta, Priyanka Jha, Timothy M Baran, et al.
American Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 12, 2020
Identification of unique clusters of T, dendritic, and innate lymphoid cells in the peritoneal fluid of ovarian cancer patientsJessica Vazquez, Melina Chavarria, Gladys E Lopez, et al.
JAMA Network Open|June 9, 2022
Diagnostic Performance of the Ovarian-Adnexal Reporting and Data System (O-RADS) Ultrasound Risk Score in Women in the United StatesPriyanka Jha, Akshya Gupta, Timothy M Baran, et al.
Gynecologic Oncology|October 10, 2021
An open-label phase I dose-escalation study of the safety and pharmacokinetics of DMUC4064A in patients with platinum-resistant ovarian cancerJoyce Liu, Howard Burris, Judy S Wang, et al.
Cancer Research|May 10, 2018
Alternatively-Activated Macrophages Upregulate Mesothelial Expression of P-Selectin to Enhance Adhesion of Ovarian Cancer CellsMolly J Carroll, Kaitlin C Fogg, Harin A Patel, et al.
Pageof 6